Research

Cancer management has drastically improved in recent years due to discoveries made in clinical trials.

In conjunction with The City of Hope, we are committed to the advancement and improvement of cancer management and prevention.

Prevention Trials

A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer (Study with National Cancer Institute of Canada) (PENDING IRB SUBMISSION)

Treatment Trials

Breast
B-35: A Clinical Trial Comparing Anastrozole with Tamoxifen in Postmenopausal Patients with Ductal Carcinoma In Situ (DCIS) Undergoing Lumpectomy with Radiation Therapyo

B-37: A Randomized Clinical Trial of Adjuvant Chemotherapy for Radically Resected Loco-Regional Relapse of Breast Cancer (IBCSG 27-02BIG 1-02). (PENDING IRB APPROVAL)

B-38: A Phase III Adjuvant Trial Comparing Three Chemotherapy Regimens in Women with Node-Positive Breast Cancer: Docetaxel/Doxorubicin/Cyclophosphamide (TAC); Dose-Dense (DD) Doxorubicin/Cyclophosphamide Followed by DD Paclitaxel (DD AC P P); DD AC Followed by DD Paclitaxel Plus Gemcitabine (DD AC P PG). (PENDING IRB APPROVAL)

  
Colon
C-08: A Phase III Clinical Trial Comparing Infusional 5-Fluorouracil (5-FU), Leucovorin, and Oxaliplatin (mFOLFOX6) Every Two Weeks with Bevacizumab to the Same Regimen without Bevacizumab for the Treatment of Patients with Resected Stages II and III Carcinoma of the Colon

  
Rectal
R-04: A Clinical Trial Comparing Preoperative Radiation Therapy and Capecitabine with Preoperative Radiation Therapy and Continuous Intravenous Infusion (CVI) of 5-Fluorouracil (5-FU) in the Treatment of Patients with Operable Carcinoma of the Rectum (PENDING IRB SUBMISSION)